erythrosine has been researched along with alloxan in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katayama, M; Taniguchi, H | 1 |
Cunha-Vaz, JG; Jones, CW; Rusin, MM | 1 |
Ashburn, FS; Pilkerton, AR; Recant, L; Smith, SS | 1 |
Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
4 other study(ies) available for erythrosine and alloxan
Article | Year |
---|---|
[Products in the fluorometric reaction of purines with 4,5-dimethyl-o-phenylenediamine after oxidation using N-bromosuccinimide].
Topics: Alloxan; Bromosuccinimide; Flavins; Fluoresceins; Oxidation-Reduction; Phenylenediamines; Purines; Quinoxalines | 1990 |
Vitreous fluorophotometry in the alloxan- and streptozocin-treated rat.
Topics: Alloxan; Animals; Blood Glucose; Fluorescein Angiography; Fluoresceins; Insulin; Male; Rats; Retinal Vessels; Streptozocin; Vitreous Body | 1982 |
Vitreous fluorophotometry in three models of experimental diabetes mellitus.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Fluoresceins; Fluorometry; Male; Pancreatectomy; Rats; Retina; Streptozocin; Vitreous Body | 1982 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |